¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"potassium channel blocking agent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • antiinflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • antimetabolic agent
    Ç×´ë»ç¹°Áú
  • antitumor agent
    Ç×¾ÏÁ¦
  • antiviral agent
    Ç×¹ÙÀÌ·¯½ºÁ¦, Ç×¹ÙÀÌ·¯½º¹°Áú
  • agent
    1. ¹°Áú 2. ÀÎÀÚ 3. -¾à, -Á¦
  • alkylating agent
    ¾Ëųȭ¾à¹°, ¾ËųȭÁ¦
  • anesthetic agent
    ¸¶ÃëÁ¦
  • biologic agent
    »ý¹°ÇÐÀûÁ¦Á¦
  • bacteriostatic agent
    Á¤±ÕÁ¦
  • bulking agent
    ÀåÈ®À强¾à¹°
  • compounding agent
    ¹èÇÕÁ¦, Á¶ÇÕÁ¦
  • contrast agent
    Á¶¿µÁ¦
  • carcinogenic agent
    ¹ß¾Ï¹°Áú
  • carcinostatic agent
    Á¦¾ÏÁ¦
  • cardioactive agent
    ½ÉÀåÀÛ¿ëÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anti-inflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • antiallergic agent
    ¾Ë·¹¸£±â¾à
  • antiarrhythmic agent
    Ç׺ÎÁ¤¸ÆÁ¦
  • antiasthmatic agent
    (¢¡antasthmatic) Ç×õ½ÄÁ¦
  • antifoaming agent
    Ç×±âÆ÷Á¦, ±âÆ÷Á¦°ÅÁ¦
  • antifungal agent
    Ç×Áø±ÕÁ¦
  • antimetabolic agent
    Ç×´ë»ç¹°Áú
  • antitumor agent
    Ç×¾ÏÁ¦
  • antiviral agent
    Ç×¹ÙÀÌ·¯½ºÁ¦, Ç×¹ÙÀÌ·¯½º¹°Áú
  • bacteriostatic agent
    Á¤±ÕÁ¦
  • biologic agent
    »ý¹°ÇÐÀûÁ¦Á¦
  • bulking agent
    ÀåÈ®À强¾à¹°
  • carcinogenic agent
    ¹ß¾Ï¹°Áú
  • carcinostatic agent
    Á¦¾ÏÁ¦
  • cardioactive agent
    ½ÉÀåÀÛ¿ë¾à
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Eaton agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ° º´¿øÃ¼
  • Eatons agent pneumonia
    ÀÌÆ°º´¿øÃ¼Æó·Å.
  • Norwalk agent
    ³ë¿öÅ© º´¿øÃ¼
  • Norwalk-like agent
    ³ë¸£¿ÍÅ©¾ç ü
  • Parvovirus-like agent
    ÆÄº¸¹ÙÀÌ·¯½º¾ç º´¿øÃ¼
  • Pittsburgh pneumonia [agent]
    ÇÇÃ÷¹ö±×Æó·Å(¿øÀÎü), ·¹Áö¿À³Ú¶óÁõ(¿øÀÎü)
  • addition agent
    ÷°¡Á¦(ôÕÊ¥ð¥).
  • alpha-sympathomimetic agent
    ¾ËÆÄ±³°¨½Å°æÀ¯»çÀÛ¿ëÁ¦
  • anesthetic agent
    ¸¶Ãë¾à, ¸¶ÃëÁ¦.
  • anorectic agent
    ½Ä¿å°¨ÅðÁ¦(ãÝé¯Êõ÷Üð¥).
  • anorexiant =anorectic agent
    ½Ä¿å°¨ÅðÁ¦(ãÝé¯Êõ÷Üð¥), ½Ä¿å¾ïÁ¦Á¦.
  • anorexigenic agent
    ½Ä¿å¾ïÁ¦Á¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • potassium losing nephritis
    Ä®·ý»ó½Ç¼º ½Å¿°.
  • potassium losing nephritis
    Ä®·ý»ó½Ç¼º ½Å¿°(¡­ßÃã÷àõ ãìæú)
  • potassium oxalate
    ¼ö»êÄ®·ý
  • potassium secretion
    Ä®·ýºÐºñ
  • potassium sparing diuretic
    Æ÷Ÿ½·<Ä®·ý>-º¸Á¸(¼º) ÀÌ´¢Á¦.
  • potassium urate crystal
    ¿ä»êÄ®·ý°áÁ¤
  • sodium-potassium pump
  • alpha blocking
    ¾ËÆÄÂ÷´Ü
  • antibody, blocking
    Â÷´ÜÇ×ü
  • blocking
    ¸·Èû, ´ÜÀý, Â÷´Ü.
  • blocking antibody
    Â÷´ÜÇ×ü(ó´Ó¨ù÷ô÷)
  • blocking antibody =blocker
    Â÷´ÜÇ×ü(¡­ù÷ô÷).
  • blocking of thought
    »ç°íÀÇ ¸·Èû
  • blocking test
    Â÷´Ü½ÃÇè(ó´Ó¨ãËúÐ).
  • depolarizing neuromuscular blocking drug
    Å»ºÐ±Ø¼º ½Å°æ±ÙºÀ¼â¾à¹°.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • lympholytic agent
    ¸²ÇÁ±¸¿ëÇØÁ¦(éÁú°ð­)
  • lysosomotropic agent
    ¶óÀ̼ÒÁ»ÀÚ±ØÁ¦(í©Ð»ð¥)
  • methylating agent
    ¸ÞƿȭÁ¦(ð¥)
  • mutagenic agent
    º¯ÀÌ¿øÁ¦(ܨì¶ê«ð¥)
  • oxidizing agent
    »êÈ­Á¦(ß«ûùð¥)
  • precipitating agent
    ħ°­Á¦(öØË½ð¥)
  • pressor agent
    Ç÷¾Ð»ó½ÂÁ¦(úìäâß¾ã°ð¥)
  • reducing agent
    ȯ¿ø ½Ã¾à(ü½êªãËå·)
  • sequestering agent
    °ÝÀýÇü¼ºÁ¦(̰ï¾û¡à÷ð¥)
  • sulfating agent
    Ȳ»êÈ­Á¦ (üÜß«ûùð¥)
  • surface-active agent
    Ç¥¸éȰ¼ºÁ¦ (øúØüüÀàõð¥)
  • transport agent
    ¼ö¼ÛÁ¦(âÃáêð¥)
  • uncoupling agent
    ¦Ǯ±âÁ¦(ð¥)
  • wetting agent
    ½ÀÆ÷Á¦(ã¥øÖð¥)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CCV channel catfish virus; conductivity cell volume
CLCN chloride channel
CNGC cyclic nucleotide gated channel
CPVC common pulmonary venous channel
DHPCCB dihydropyridine calcium channel blocker
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
K(ATP) ATP sensitive potassium
LPD Low Potassium Dextran
PK Potassium
KTP Potassium-titanyl-phosphate
Na-K ATPase and potassium activated adenosine triphosphatase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • agent
    ¾à¹°, ¾à¹°Á¦, ÀÛ¿ë¹°Áú, º´ÀÎ
    ¹°¸®Àû, È­ÇÐÀû ¶Ç´Â »ý¹°ÇÐÀûÀÎ È¿°ú¸¦ ÀÏÀ¸Å°´Â Èû, ¼ººÐ ¶Ç´Â ¹°Áú.
  • anabolic agent
    µ¿È­ ¾à¹°
  • analgesic agent
    ÁøÅëÁ¦
    ½Å°æÀ» ¸¶ºñ½ÃÄÑ ¾ÆÇÄÀ» ÁøÁ¤½ÃŰ´Â ¾àÁ¦. ¸ôÇÉ, ¾ÈƼÇǸ° µîÀÌ ÀÖ´Ù.
  • anesthetic agent
    ¸¶Ãë¾à, ¸¶Ãë, ¸¶ÃëÁ¦
    µ¿ÀǾî=anesthetic drug.
  • anorexigenic agent
    ½Ä¿å ¾ïÁ¦Á¦
  • anti-inflammatory agent
    Ç׿°Áõ ¾à, ¼Ò¿°Á¦, Ç׿°ÁõÁ¦
    ¿°Áõ¿¡ ¹Ý´ë·Î ÀÛ¿ëÇϰųª ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â ¾àÁ¦.
  • anti-viral agent
    Ç×¹ÙÀÌ·¯½ºÁ¦
    ¹ÙÀÌ·¯½º¸¦ º´¿øÃ¼·Î ÇÏ´Â Áúº´. Áï, Æ®¶óÄÚ¸¶¡¤¼Ò¾Æ¸¶ºñ
  • antiallergic agent
    Ç׾˷¹¸£±â ¾à
  • anticariogenic agent
    Ç׿ì½Ä¼º ¾à, Ç׿ì½Ä¼º ÀÎÀÚ
    ¿ì½Ä ¿¹¹æ¿¡ È¿°ú°¡ ÀÖ´Â ¾àÁ¦.
  • antifibrinolytic agent
    Ç×¼¶À¯¼Ò ¿ëÇØÁ¦
  • antifoaming agent
    ¼ÒÆ÷Á¦
    µ¿ÀǾî=defoaming.
  • antifungal agent
    Ç×Áø±Õ ¾à, Ç×Áø±Õ ¹°Áú, Ç×Áø±Õ ÀÎÀÚ, Ç×°õÆÎÀÌ ¾à
  • antineoplastic agent
    Ç×Á¾¾çÁ¦
  • antiparasympathetic agent
    Ç׺α³°¨½Å°æ, Ç׺α³°¨½Å°æ¼º
  • antitubercular agent
    Ç×°áÇÙÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
channel protein <chemistry, physiology> A protein that facilitates the diffusion of molecules/ions across lipid membranes by forming a hydrophilic pore. most frequently multimeric with the pore formed by subunit interactions.
(18 Nov 1997)
channel transport <radiobiology> In inertial fusion research using light ion drivers, describes the use of current-carrying plasma channels (which are magnetically confined to the channel) to transport electron or ion beams between the ion diode and the fusion target. This allows the ion source to stand back from the target.
(09 Oct 1997)
chloride channel Ion channels selective for chloride ions. Various types including ligand activated Cl channels at synapses (the GABA and glycine activated channels), as well as voltage gated Cl channels found in a variety of plant and animal cells.
See: CFTR, MDR.
(18 Nov 1997)
ryanodine receptor calcium release channel Protein complexes that mediate the release of calcium from the sarcoplasmic reticulum in both skeletal and cardiac muscle cells by forming tetrametric complexes. These complexes each then act as a calcium channel. There are three isoforms of the ryr: ryr1, ryr2, and ryr3. Ryr1 is specifically expressed in skeletal muscles and ryr2 in cardiac muscles. Ryr3 is yet another isoform found in non-muscle cells such as neuronal cells.
(12 Dec 1998)
single channel recording Variant of patch clamp technique.
(18 Nov 1997)
sodium channel <neurology, physiology> The protein responsible for electrical excitability of neurons. A transmembrane ion channel, containing an aqueous pore around 0.4nm diameter, with a negatively charged region internally (the selectivity filter) to block passage of anions.
The channel is voltage gated: it opens in response to a small depolarisation of the cell (usually caused by an approaching action potential), by a multistep process.
Around 1000 sodium ions pass in the next millisecond, before the channel spontaneously closes (an event with single step kinetics). The channel is then refractory to further depolarisations until returned to near the resting potential.
There are around 100 channels per square micron in unmyelinated axons, in myelinated axons, they are concentrated at the nodes of Ranvier. The sodium channel is the target of many of the deadliest neurotoxins.
(18 Nov 1997)
delayed rectifier channel <physiology> The potassium selective ion channels of axons, so called because they change the potassium conductance with a delay after a voltage step.
The name is used to denote any axon like K channel. Various roles for example regulation of pacemaker potentials, generation of bursts of action potentials or generation of long plateaus on action potentials.
(18 Nov 1997)
double-channel catheter A catheter with two lumens, allowing irrigation and aspiration.
Synonym: two-way catheter.
(05 Mar 2000)
ion channel <cell biology> A transmembrane pore that presents a hydrophilic channel for ions to cross a lipid bilayer down their electrochemical gradients.
Some degree of ion specificity is usually observed and typically a million ions per second may flow. Channels may be permanently open, like the potassium leak channel or they may be voltage gated, like the sodium channel or ligand gated like the acetylcholine receptor.
(27 Oct 1998)
ion channel gating The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential (voltage-gated), drugs or chemical transmitters (ligand-gated), or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability.
(12 Dec 1998)
transnexus channel A hexagonal 15-20A
ligand-gated channel A class of ion channel's whose ionic permeability is regulated by cell membrane receptors that respond to specific extracellular chemical signals.
(05 Mar 2000)
ligand gated ion channel A transmembrane ion channel whose permeability is increased by the binding of a specific ligand, typically a neurotransmitter at a chemical synapse. The permeability change is often drastic, such channels let through effectively no ions when shut, but allow passage at up to 10exp7 ions sexp 1 when a ligand is bound. Recently, the receptors for both acetylcholine and GABA have been found to share considerable sequence homology, implying that there may be a family of structurally related ligand gated ion channels.
(18 Nov 1997)
alpha-phenoxyethylpenicillin potassium A penicillin preparation that is stable in gastric acid and is rapidly but only partially absorbed from the gastrointestinal tract.
Synonym: alpha-phenoxyethylpenicillin potassium, penicillin B.
(05 Mar 2000)
alpha-phenoxypropylpenicillin potassium A semisynthetic acid-stable penicillin that may be more effective than penicillin G.
Synonym: alpha-phenoxypropylpenicillin potassium.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • commission agent
    °Å°£²Û;Á߸ÅÀÎ;»ç¼³ ¸¶±ÇÀå¼ö
  • consular agent
    ¿µ»ç ´ë¸®
  • contact agent
    Ã˸Å;Á¢ÃËÁ¦(catalyzer)
  • conversion agent
    Àüȯ ´ë¸® ±â°ü
  • county agent
    (¿¬¹æ.ÁÖÁ¤ºÎ°¡ ÆÄ°ßÇÑ)³ó»ç °í¹®
  • double agent
    ÀÌÁß °£Ã¸
  • estate agent
    ºÎµ¿»ê°ü¸®ÀÎ;Áß°³¾÷ÀÚ
  • fiscal agent
    À繫 ´ë¸® ±â°ü;À繫 ´ë¸®ÀÎ
  • forwarding agent
    ¿î¼Û¾÷ÀÚ
  • free agent
    ÀÚÁÖÀûÀÎ ÇàÀ§ÀÚ;ÀÚÀ¯°è¾à ¼±¼ö )
  • general agent
    ÃѴ븮ÀÎ
  • house agent
    º¹´ö¹æ;°¡¿Á ¸Å¸Å ¼Ò°³¾÷ÀÚ
  • inquiry agent
    (¿µ)»ç½Ç ŽÁ¤
  • insurance agent
    º¸Çè´ë¸®Á¡
  • land agent
    ÅäÁö ¸Å¸Å Áß°³¾÷ÀÚ;ÅäÁö °ü¸®ÀÎ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á